http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2339379-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ee484f4ba9a0406b8927b5be6c4f2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593
filingDate 2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f99e05e74eab6792b83e8ff9939c2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0885438f767d7bd0986ab9a1384c88b
publicationDate 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2339379-C1
titleOfInvention Method for optimisation of thrombocyte receptivity to aggregation inducers in metabolic syndrome
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, particularly to haematology and endocrinology, and deals with optimisation of thrombocyte receptivity to aggregation inducers in metabolic syndrome patients. For this purpose individually selected low-calorie diet, and drugs: 10 mg amploidine every morning, duovit by 1 red tablet and 1 blue one daily, are administered. The course duration is at least 12 weeks. n EFFECT: allows normalisation of thrombocyte receptivity to aggregation inducers, resulted in significant reducing the risk of thrombosis complications in metabolic syndrome. n 2 tbl, 1 ex, 3 dwg
priorityDate 2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521

Total number of triples: 26.